Janus Henderson Biotech Innovation Fund II Access LLC is a hedge fund based in New York, New York. According to its most recent Form D, filed Oct 13, 2026, the fund has sold $155,006,441 of interests to 610 investors since its first sale in Sep 2025. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Asterion Fund Services, L.L.C; Maples Fiduciary Services (Delaware) Inc; iCapital Alternative Investments LLC.
Performance
No verified returns have been reported for this fund. Hedge fund returns are not part of SEC filings; managers report them to AltMountain directly.
Is this your fund? Report your monthly returns · How performance works
- Total raised
- $155,006,441Cumulative sales reported on Form D
- Investors
- 610
- First sale
- Sep 1, 2025
- Minimum investment
- None set
- Who can invest
- Qualified purchasersSection 3(c)(7): generally $5M+ in investments
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Asterion Fund Services, L.L.C; Maples Fiduciary Services (Delaware) Inc; iCapital Alternative Investments LLC
- Latest Form D
- Oct 13, 2026
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about Janus Henderson Biotech Innovation Fund II Access LLC
What is the minimum investment for Janus Henderson Biotech Innovation Fund II Access LLC?
Janus Henderson Biotech Innovation Fund II Access LLC's latest Form D, filed Oct 13, 2026, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in Janus Henderson Biotech Innovation Fund II Access LLC?
Janus Henderson Biotech Innovation Fund II Access LLC is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.
How much has Janus Henderson Biotech Innovation Fund II Access LLC raised?
Janus Henderson Biotech Innovation Fund II Access LLC reports $155,006,441 sold from 610 investors on its Form D filed Oct 13, 2026. This is cumulative sales since the offering began, not current assets or performance.
Where is Janus Henderson Biotech Innovation Fund II Access LLC based?
Janus Henderson Biotech Innovation Fund II Access LLC is based in New York, New York.
When did Janus Henderson Biotech Innovation Fund II Access LLC launch?
Janus Henderson Biotech Innovation Fund II Access LLC reports its first sale in Sep 2025.
Size compared with every hedge fund
Raised more than 61% of the 2,544 hedge funds based in New York, and more than 65% of all 10,308 that report sales.